Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
David Martin, Charles D. Nichols
EBioMedicine September 1, 2016 DOI: 10.1016/j.ebiom.2016.08.049 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Excitatory neurons expressing 5-HT2A receptors in the brain |
| Keywords | Parvalbumin Gabaergic Inhibitory postsynaptic potential |
| Citations | 88 |
| Key findings | Psychedelics directly activate a small subset of 5-HT2A-expressing excitatory neurons, which subsequently recruit inhibitory somatostatin and parvalbumin GABAergic interneurons and astrocytes to produce distinct regional responses. |
Abstract
There has recently been a resurgence of interest in psychedelics, substances that profoundly alter perception and cognition and have recently demonstrated therapeutic efficacy to treat anxiety, depression, and addiction in the clinic. The receptor mechanisms that drive their molecular and behavioral effects involve activation of cortical serotonin 5-HT 2A receptors, but the responses of specific cellular populations remain unknown. Here, we provide evidence that a small subset of 5-HT 2A -expressing excitatory neurons is directly activated by psychedelics and subsequently recruits other select cell types including subpopulations of inhibitory somatostatin and parvalbumin GABAergic interneurons, as well as astrocytes, to produce distinct and regional responses. To gather data regarding the response of specific neuronal populations, we developed methodology for fluorescence-activated cell sorting (FACS) to segregate and enrich specific cellular subtypes in the brain. These methods allow for robust neuronal sorting based on cytoplasmic epitopes followed by downstream nucleic acid analysis, expanding the utility of FACS in neuroscience research.
Citations in the library
Cited by 64
- Psychedelics as Medicines: An Emerging New Paradigm Clinical Pharmacology & Therapeutics November 4, 2016
- The neural basis of psychedelic action. Nature Neuroscience October 24, 2022
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Models of psychedelic drug action: modulation of cortical-subcortical circuits Brain October 22, 2021
- Psilocybin: from ancient magic to modern medicine The Journal of Antibiotics May 12, 2020
and 59 more in the library
Cites 29
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 24 more in the library